SCHEMBL16611598

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL16610802	0.87	SRC (0.41)	XDHKDM5ABTKKDM4EGAA
	SCHEMBL16610767	0.82	MTOR (0.36)	XDHKDM5AROCK2UCHL1BTK
	SCHEMBL16611405	0.82	BMPR1A (0.38)	XDHKDM5AAURKATTKAURKB
	SCHEMBL16611028	0.82	LRRK2 (0.42)	XDHBTK
	SCHEMBL16611359	0.82	KDM5A (0.42)	XDHKDM5A
	SCHEMBL16611384	0.82	BRD4 (0.39)	FLT3TYRO3MERTKBTK
	SCHEMBL16611419	0.81	XDH (0.39)	XDHAXLFLT3TYRO3MERTK
	SCHEMBL16610735	0.81	KDM5A (0.42)	XDHKDM5ABTK
	SCHEMBL16611255	0.80	CHUK (0.40)	XDHBTK
	SCHEMBL16611087	0.80	CDK2 (0.40)	XDHFLT3TYRO3MERTKBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.